Mercer Global Advisors’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$567K Buy
121,726
+45,202
+59% +$199K ﹤0.01% 2342
2026
Q2
$295K Buy
76,524
+42,063
+122% +$154K ﹤0.01% 2828
2026
Q1
$136K Buy
34,461
+13,675
+66% +$68.9K ﹤0.01% 2940
2025
Q4
$141K Buy
20,786
+5,236
+34% +$36.7K ﹤0.01% 2654
2025
Q3
$109K Buy
+15,550
New +$108K ﹤0.01% 2506
2022
Q2
– Sell
-12,000
Closed -$57K – 1882
2022
Q1
$57K Hold
12,000
– – ﹤0.01% 1832
2021
Q4
$72K Sell
12,000
-42,200
-78% -$293K ﹤0.01% 1739
2021
Q3
$328K Hold
54,200
– – ﹤0.01% 1385
2021
Q2
$678K Buy
+54,200
New +$587K 0.01% 1009

Other funds holding MDXG

Mercer Global Advisors's MDXG Position: Q3 2026 in Review

Mercer Global Advisors increased its MiMedx Group (MDXG) stake by 59% in Q3 2026, buying an estimated $199K and bringing the position to 121,726 shares worth $567K. The position accounts for ﹤0.01% of the portfolio, ranked #2342.

Mercer Global Advisors first reported a position in MDXG in Q2 2021 and has held it in 9 quarters since. The position peaked at $678K in Q2 2021. 219 funds tracked by Wall St. Rank hold MDXG as of Q3 2026.

  • Mercer Global Advisors held 121,726 shares of MiMedx Group worth $567K as of Q3 2026.
  • Mercer Global Advisors bought 45,202 MiMedx Group shares in Q3 2026, an estimated $199K.
  • MiMedx Group made up ﹤0.01% of Mercer Global Advisors's portfolio in Q3 2026, its #2342 holding.
  • Mercer Global Advisors first reported a position in MiMedx Group in Q2 2021 and has held it in 9 quarters since.
  • Mercer Global Advisors's MiMedx Group position peaked at $678K in Q2 2021.
  • 219 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2026.

Based on Mercer Global Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.